close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

The RIQAS Serum Indices EQA Programme is designed for the pre-analytical assessment of haemolytic, Icteric and Lipemic (HIL) interferences. The option to report either quantitative or semi-quantitative results for the HIL parameters, provides an assessment on how these interferences impact on up to 25 routine chemistry parameters, offering an invaluable insight into whether a correct judgement is being made when reporting results.

Cycle Starts - October 2026

Not Accredited

Get in touch to discover more

To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.

DescriptionFrequencySizeCat No
Serum IndicesBi-Monthly (9 samples per distribution) 2 distributions per cycle2 x (9 x 1 ml)RQ9194

NOTE: For additional Serum Indices EQA material, purchase RQ9194/A. This is an additional pack containing 9 x 1ml vials to be used as a supplement to your main RQ9194 Serum Indices programme.

Parameters

Indices Assessment (Quantitative and Semi-Quantitative)

  • Haemolysis
  • Icteric
  • Lipaemic

Parameter Assessment (Quantitative)

  • ALP
  • ALT
  • AST
  • Bilirubin (Direct)
  • Bilirubin (Total)
  • Calcium
  • Chloride
  • Cholesterol
  • CK NAC
  • Creatinine
  • GGT
  • Glucose
  • HDL
  • Iron
  • Lactate
  • LDH
  • Lipase
  • Magnesium
  • Phosphate
  • Potassium
  • Protein (Total)
  • Sodium
  • Triglycerides
  • Urea
  • Uric Acid

Related RIQAS EQA Programmes

General Clinical Chemistry

Lipid

Neonatal Bilirubin

Acusera QC
Complete QC Solutions for Results you Can Trust
RIQAS Brochure
Randox International Quality Assessment Scheme
QCMD
QCMD EQA/PT Schemes for Molecular Infectious Disease Testing.